Psychedelic drug provides relief for veterans with PTSD

A psychedelic party drug continues to show promise as a treatment option for patients with chronic post-traumatic stress disorder, a new study shows.

The study, published in the Lancet Psychiatry journal earlier this month, found that MDMA, the main ingredient in ecstasy or molly, dramatically reduced PTSD symptoms in study participants.

Doctors treated 26 first responders during two, day-long psychotherapy sessions that featured full doses of MDMA. The majority of the study’s participants were combat veterans.

More